Getting your player ready...
For those who don’t like to drool, slur their speech or unknowingly bite their tongue after a visit to the dentist, help might be at hand.
A small drug company said it won approval Friday from the Food and Drug Administration to market the first drug meant to undo the effects of local dental anesthesia.
In clinical trials, the drug cut the median time it took for full sensation to return to the lips by about 75 minutes to 85 minutes, or by more than half.
The drug, OraVerse, was developed by San Diego-based Novalar Pharmaceuticals, which said it would begin selling the drug to dentists late this year for $12.50 an injection.
